Development of myelin oligodendrocyte glycoprotein autoreactive transgenicB lymphocytes: Receptor editing in vivo after encounter of a self-antigen distinct from myelin oligodendrocyte glycoprotein
T. Litzenburger et al., Development of myelin oligodendrocyte glycoprotein autoreactive transgenicB lymphocytes: Receptor editing in vivo after encounter of a self-antigen distinct from myelin oligodendrocyte glycoprotein, J IMMUNOL, 165(9), 2000, pp. 5360-5366
We explored mechanisms involved in B cell self-tolerance against brain auto
antigens in a double-transgenic mouse model carrying the Ig H-chain (introd
uced by gene replacement) and/or the L-chain K (conventional transgenic) of
the mAb 8.18C5, specific for the myelin oligodendrocyte glycoprotein (MOG)
. Previously, we demonstrated that B cells expressing solely the MOG-specif
ic Ig H-chain differentiate without tolerogenic censure. We show now that d
ouble-transgenic (TH kappa (mog)) B cells expressing transgenic Ig H- and L
-chains are subjected to receptor editing. We show that in adult mice carry
ing both MOG-specific Ig H- and L-chains, the frequency of MOG-binding B ce
lls is not higher than in mice expressings solely the transgenic Ig H-chain
, In fact, in TH kappa (mog) double-transgenic mice, the transgenic kappa (
mog) L-chain was commonly replaced by endogenous L-chains, i.e., by recepto
r editing. In rearrangement-deficient RAG-2(-) mice, differentiation of TH
kappa (mog) B cells is blocked at an immature stage (defined by the B220(lo
w)IgM(low)IgD(-) phenotype), reflecting interaction of the autoreactive B c
ells with a local self-determinant, The tolerogenic structure in the bone m
arrow is not classical MOG, because back-crossing TH kappa (mog) mice into
a MOG-deficient genetic background does not lead to an increase in the prop
ortion of MOG-binding B cells. We propose that an as yet undefined self-Ag
distinct from MOG cross-reacts with the TH kappa (mog) B cell receptor and
induces editing of the transgenic kappa (mog) L-chain in early immature B c
ells without affecting the pathogenic potential of the remaining MOG-specif
ic B cells, This phenomenon represents a particular form of chain-specific
split tolerance.